People With a Personal or Family History of Thyroid Cancer This is the clearest contraindication
That matters because interest has moved faster than the approval process
The pricing is competitive, especially on longer plans: $283/month for tirzepatide on the 12-month plan
Latest Clinical Data on Weight Loss Drugs Metsera - MET-097 Om September 24, 2024, Metsera announced that its long-acting weight loss therapy, MET-097, achieved significant and lasting weight loss effects in a phase 1 clinical trial
In addition to mimicking GLP-1 and GIP, retatrutide also targets the glucagon receptor, a crucial hormone in glucose and lipid metabolism, further enhancing body weight loss
Patients must see a doctor at our clinic before pickup, with a prior appointment required